Advanced Imaging Tools in the Study of Mild Traumatic Brain Injury
mTBI
1 other identifier
observational
20
1 country
1
Brief Summary
We will utilize a set of imaging modalities including computed tomography (CT), positron emission tomography (PET), and a suite of magnetic resonance imaging (MRI) tools, to investigate the changes in the human brain resulting from mild traumatic brain injury (mTBI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2010
CompletedFirst Posted
Study publicly available on registry
January 8, 2010
CompletedStudy Start
First participant enrolled
December 1, 2010
CompletedJanuary 14, 2013
January 1, 2013
January 6, 2010
January 10, 2013
Conditions
Keywords
Study Arms (2)
Mild traumatic brain injury patients
Subjects who have a verifiable diagnosis of mild traumatic brain injury sustained within 24 months prior to enrollment
Normal Control
Normal, healthy adults with no history of brain injury.
Eligibility Criteria
Patients at Veteran's Administration Medical Center in Dayton, OH who have history of Mild Traumatic Brain Injury within 24 months prior to enrollment.
You may qualify if:
- Study group:
- Between 18 and 55 years of age inclusive.
- Potential participant verbally verifies diagnosis of mTBI at pre-screen.
- Diagnosed with mild traumatic brain injury by a VAMC physician according to standard diagnostic criteria \[12\],\[13\], to be verified by chart review.
- Less than 24 months from trauma resulting in mTBI.
- Able to read and write in English.
- Willingness to refrain from nicotine, and beverages containing either alcohol or caffeine for at least four hours prior to the imaging session.
- Have signed the consent form for the study.
- Control Group:
- Between 18 and 55 years of age inclusive.
- Potential participant verbally denies history of mTBI at pre-screen.
- Able to read and write in English.
- Willingness to refrain from nicotine, and beverages containing either alcohol or caffeine for at least four hours prior to the imaging session.
- Have signed the consent form for the study
You may not qualify if:
- Conditions that would preclude the completion of a MRI, PET, or CT exam such as claustrophobia, pacemaker, metal objects in body, and/or pregnancy.
- Serious, unstable medical or mental illness.
- Medical contraindication to any element of the study procedure.
- Have not read and signed an informed consent form, or do not understand its contents.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kettering Health Networklead
- University of Cincinnaticollaborator
Study Sites (1)
Kettering Health Network
Kettering, Ohio, 45429, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Parker, PhD
Kettering Health Network
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 6, 2010
First Posted
January 8, 2010
Study Start
December 1, 2010
Last Updated
January 14, 2013
Record last verified: 2013-01